SNCA and Parkinson disease: Coincidentally, the hypoglycemic agent metformin that induces nuclear retention of AUF1 disrupting its interaction with target mRNAs [31], is neuroprotective in different PD models in part by decreasing SNCA levels [32], phosphorylation [33,34] and aggregation [35].